Immunoassay testing

Ended Awarded Last action

Contract number
N6890821F0020
Awardee
Awarding agency
Obligated
$40,071

Award facts

Opportunity
  • N6890821Q0048 Solicitation number
Contract value 29% obligated
$137,442.78 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Beaufort, SC 29902, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00014 $15,065
Supplemental Agreement for work within scope P00013 $0
Exercise an Option P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $1,000
Supplemental Agreement for work within scope P00009 -$78,766
Supplemental Agreement for work within scope P00008 -$10,027
Funding Only Action P00007 $33,644
Exercise an Option P00006 $0
Exercise an Option P00005 $58,842
Other Administrative Action P00004 $58,842
Supplemental Agreement for work within scope P00003 $20,313
Exercise an Option P00002 $0
Funding Only Action P00001 $38,529
Original award $0
Show all 15

About this award

Beckman Coulter, Inc., a subsidiary of Danaher Corporation, was awarded a delivery order valued at $137,442.78 by the Defense Health Agency for immunoassay testing services. The contract, awarded on October 1, 2021, represents a firm fixed-price delivery order with a performance location in Beaufort, South Carolina, and an ultimate completion date of March 31, 2026. This award was issued without a set-aside designation, indicating competitive procurement in the open federal market. The delivery order falls under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, leveraging Beckman Coulter's established position as a leading provider of clinical laboratory equipment and diagnostic services to federal healthcare agencies.

Beckman Coulter maintains an extensive contracting relationship with the Defense Health Agency and broader federal healthcare system, delivering automated laboratory instrumentation and cost-per-reportable-result solutions across multiple diagnostic testing domains including immunochemistry, chemistry, urinalysis, hematology, and microbiology. The company holds multiple significant indefinite delivery vehicles with the Defense Health Agency totaling over $4.4 million, demonstrating its critical role in supporting federal medical facility laboratory operations. This immunoassay testing delivery order aligns with the Defense Health Agency's healthcare delivery mission and reflects Beckman Coulter's capability to provide sophisticated diagnostic technologies essential to military medicine and federal healthcare delivery.

Quick answers

Who was awarded contract N6890821F0020?

N6890821F0020 was awarded to Beckman Coulter, Inc. by Defense Health Agency (Department of Defense) on October 1, 2021.

How much is contract N6890821F0020 worth?

The government has obligated $40,071 on N6890821F0020. Its current value, with exercised options, is $137,443.

Is contract N6890821F0020 an order under another contract?

Yes. N6890821F0020 is a delivery order under V797D70260, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract N6890821F0020 competed?

The extent of competition for N6890821F0020 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award